Aksoy, F. Et Al. 2023. High expression of SNGH16 is a candidate predictive marker of regional therapy resistance in hepatocellular carcinoma. Joint International Congress of the ILTS, ELITA and LICAGE , (Rotterdam, Netherlands), 92.

Aksoy, F., AKSOY, M. S., Ercelik, M., Tekin, C., Tunca, B., GÜRLÜLER, E., ... Kaya, E.(2023). High expression of SNGH16 is a candidate predictive marker of regional therapy resistance in hepatocellular carcinoma . Joint International Congress of the ILTS, ELITA and LICAGE (pp.92). Rotterdam, Netherlands

Aksoy, F. Et Al. "High expression of SNGH16 is a candidate predictive marker of regional therapy resistance in hepatocellular carcinoma," Joint International Congress of the ILTS, ELITA and LICAGE, Rotterdam, Netherlands, 2023

Aksoy, F. Et Al. "High expression of SNGH16 is a candidate predictive marker of regional therapy resistance in hepatocellular carcinoma." Joint International Congress of the ILTS, ELITA and LICAGE , Rotterdam, Netherlands, pp.92, 2023

Aksoy, F. Et Al. (2023) . "High expression of SNGH16 is a candidate predictive marker of regional therapy resistance in hepatocellular carcinoma." Joint International Congress of the ILTS, ELITA and LICAGE , Rotterdam, Netherlands, p.92.

@conferencepaper{conferencepaper, author={F. Aksoy Et Al. }, title={High expression of SNGH16 is a candidate predictive marker of regional therapy resistance in hepatocellular carcinoma}, congress name={Joint International Congress of the ILTS, ELITA and LICAGE}, city={Rotterdam}, country={Netherlands}, year={2023}, pages={92} }